|
|
|
Volumn 148, Issue 22, 2006, Pages 33-34
|
|
Chemotherapy in cancer of the lung;Chemotherapie des lungenkarzinoms: Lebensverlängerung und symptomkontrolle als ziel
a
|
|
Author keywords
Alkylating agents; Chemotherapy; Lung cancer; Mitosis inhibitors; Targeted therapy
|
|
Indexed keywords
BEVACIZUMAB;
CARBOPLATIN;
CETUXIMAB;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
EPIRUBICIN;
ERLOTINIB;
ETOPOSIDE;
GEFITINIB;
GEMCITABINE;
IFOSFAMIDE;
IRINOTECAN;
MITOMYCIN C;
NAVELBINE;
OXALIPLATIN;
PACLITAXEL;
PEMETREXED;
TOPOTECAN;
VINBLASTINE;
VINCRISTINE;
VINDESINE;
ANTINEOPLASTIC AGENT;
CANCER CHEMOTHERAPY;
CANCER STAGING;
DRUG MECHANISM;
HUMAN;
LUNG CANCER;
LUNG NON SMALL CELL CANCER;
PREOPERATIVE CARE;
SHORT SURVEY;
ADJUVANT CHEMOTHERAPY;
ARTICLE;
DRUG DELIVERY SYSTEM;
LUNG TUMOR;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
SMALL CELL CARCINOMA;
SURVIVAL;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CARCINOMA, SMALL CELL;
CHEMOTHERAPY, ADJUVANT;
COMBINED MODALITY THERAPY;
DRUG DELIVERY SYSTEMS;
HUMANS;
LUNG NEOPLASMS;
NEOPLASM STAGING;
SURVIVAL ANALYSIS;
|
|
EID: 33749259781
PISSN: 14383276
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (1)
|
|
References (0)
|
